Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-24 Purchase | 2023-05-26 4:20 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 1,900 | $5.1528 | $9,790 | 2,715,145 (Indirect Direct) | View |
| 2023-05-24 Purchase | 2023-05-25 4:07 pm | Prelude Therapeutics Inc | PRLD | Lim Bryant David Chief Legal Officer, Corp Sec. | 2,400 | $5.39 | $12,936 | 2,400 (Direct) | View |
| 2023-05-23 Purchase | 2023-05-25 4:05 pm | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 5,000 | $5.5 | $27,500 | 42,165 (Direct) | View |
| 2023-05-23 Purchase | 2023-05-25 4:03 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 11,856 | $5.63 | $66,749 | 2,713,245 (Indirect Direct) | View |
| 2023-05-22 Purchase | 2023-05-24 5:09 pm | Prelude Therapeutics Inc | PRLD | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner | 869,565 | $5.75 | $4,999,999 | 10,646,056 (Indirect) | View |
| 2023-05-22 Purchase | 2023-05-24 5:07 pm | Prelude Therapeutics Inc | PRLD | Bonita David P Director 10% Owner | 869,565 | $5.75 | $4,999,999 | 10,646,056 (Indirect) | View |
| 2023-04-06 Sale | 2023-04-06 6:19 pm | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 13,280 | $6.12 | $81,274 | 136,720 (Direct) | View |
| 2022-12-20 Purchase | 2022-12-21 4:08 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 19,188 | $5.1306 | $98,446 | 2,701,389 (Indirect Direct) | View |
| 2022-12-08 Purchase | 2022-12-12 09:13 am | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 10,000 | $4.76 | $47,600 | 35,873 (Direct) | View |
| 2022-06-01 Purchase | 2022-06-01 4:31 pm | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 10,000 | $4.23 | $42,300 | 24,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-04 Exercise | 2023-10-06 09:07 am | N/A N/A | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 9,375 | $0 | 133,478 (Direct) | View |
| 2023-07-04 Tax Withholding | 2023-07-06 4:35 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 3,242 | $4.65 | 133,478 (Direct) | View |
| 2023-07-04 Exercise | 2023-07-06 4:35 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 9,375 | $0 | 133,478 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:47 pm | N/A 2033-06-15 | Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 47,000 | $0 | 47,000 (Indirect) | View |
| 2023-06-16 Option Award | 2023-06-21 4:16 pm | N/A 2033-06-15 | Prelude Therapeutics Inc | PRLD | Sandor Victor Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:14 pm | N/A 2033-06-15 | Prelude Therapeutics Inc | PRLD | FRIEDMAN PAUL A Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:13 pm | N/A 2033-06-15 | Prelude Therapeutics Inc | PRLD | Dier Mardi Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:12 pm | N/A 2033-06-15 | Prelude Therapeutics Inc | PRLD | Bonita David P Director 10% Owner | 23,500 | $0 | 23,500 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:11 pm | N/A 2033-06-15 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2023-05-22 Option Award | 2023-05-24 4:12 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 1,448,222 | $5.75 | 18,765,329 (Indirect) | View |
| 2023-05-22 Option Award | 2023-05-24 4:12 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 11,595,256 | $5.7499 | 18,765,329 (Indirect) | View |
| 2023-04-04 Exercise | 2023-04-06 6:19 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 37,500 | $0 | 136,720 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:06 pm | N/A 2033-02-28 | Prelude Therapeutics Inc | PRLD | Lim Bryant David Chief Legal Officer, Corp Sec. | 250,000 | $0 | 250,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:08 pm | N/A 2033-02-06 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:08 pm | N/A 2033-02-06 | Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:07 pm | N/A 2033-02-06 | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:07 pm | N/A 2033-02-06 | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:07 pm | N/A 2033-02-06 | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 330,000 | $0 | 330,000 (Direct) | View |
| 2022-12-21 Option Award | 2022-12-22 4:05 pm | N/A 2032-12-20 | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:14 pm | N/A 2032-06-16 | Prelude Therapeutics Inc | PRLD | Sandor Victor Director | 34,300 | $0 | 34,300 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:14 pm | N/A 2032-06-16 | Prelude Therapeutics Inc | PRLD | FRIEDMAN PAUL A Director | 34,300 | $0 | 34,300 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:13 pm | N/A 2032-06-16 | Prelude Therapeutics Inc | PRLD | Dier Mardi Director | 34,300 | $0 | 34,300 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:13 pm | N/A 2032-06-16 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 31,293 | $0 | 31,293 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:13 pm | N/A 2032-06-16 | Prelude Therapeutics Inc | PRLD | Bonita David P Director 10% Owner | 34,300 | $0 | 34,300 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:06 pm | N/A 2032-06-16 | Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 34,300 | $0 | 34,300 (Indirect) | View |
| 2022-05-02 Option Award | 2022-05-04 5:46 pm | N/A 2032-04-30 | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 610,000 | $0 | 610,000 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-04 5:08 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry | 36,062 | $1.89 | 354,839 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-04 5:08 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry | 36,062 | $0 | 354,839 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-22 6:01 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 6,500 | $7.51 | 14,500 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 7:12 pm | N/A 2032-02-14 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 7:11 pm | N/A 2032-02-14 | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 7:09 pm | N/A 2032-02-14 | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 327,900 | $0 | 327,900 (Direct) | View |